If any of the following side effects occur while taking amphotericin b cholesteryl sulfate, check with your doctor or nurse as soon as possible:
General reactions such as fever and chills/rigors have been reported in  of patients.
These symptoms usually begin within  to  hours of initiation of an amphotericin B cholesteryl sulfate infusion and diminish with subsequent infusions.
Slowing the rate of infusion may control symptoms.
Severe infusion-related side effects associated with conventional amphotericin B administration have been lessened by pretreatment/treatment with corticosteroids, acetaminophen, antihistamines, and meperidine.
Renal toxicity has been reported less frequently with amphotericin B cholesteryl sulfate than with conventional amphotericin B.
Increased serum creatinine, BUN, and hypokalemia have occurred in patients receiving amphotericin B cholesteryl sulfate.
Acute kidney failure, abnormal renal function including oliguria, albuminuria, dysuria, glycosuria, and urinary incontinence and retention have been reported.
Metabolic changes have occurred less frequently with amphotericin B cholesteryl sulfate than with conventional amphotericin B.
Decreased serum concentrations of potassium, magnesium, sodium, and calcium often accompany amphotericin-induced nephrotoxicity and patients may require replacement therapy.
Hyperglycemia, hypervolemia, and weight gain/loss have been reported.
Common gastrointestinal side effects, including nausea, vomiting, and diarrhea have been reported.
Gastrointestinal hemorrhage, abdominal pain, stomatitis, anorexia, dyspepsia, epigastric pain, cramping, malaise, and constipation have occurred less frequently.
Hematologic abnormalities associated with amphotericin B lipid complex therapy have occurred infrequently.
Thrombocytopenia, anemia, coagulation defects, and altered leukocyte counts have been reported.
Nervous system side effects including headache, insomnia, anxiety, and confusion, convulsions, coma, peripheral neuropathy, and somnolence have occurred.
Hypersensitivity may present as bronchospasm, wheezing, or anaphylactoid reactions.
Cell mediated immunological reactions have occurred.
Cardiac side effects (primarily infusion-related) have occurred in approximately  of patients receiving amphotericin B cholesteryl sulfate.
Side effects have included hypertension, hypotension, and tachycardia.
Cardiac failure/arrest, chest pain, vasodilation, cardiomyopathy, and arrhythmias have been reported infrequently.
Infusion-related respiratory side effects have included dyspnea, and hypoxia.
Increased cough, rhinitis, respiratory insufficiency/failure, hyperventilation, pneumonia, asthma, hemoptysis, and lung edema have been reported in treated patients.
Dermatologic side effects have included alopecia, dry skin, skin discoloration, maculopapular rash, pruritus, sweating, flushing, and ulceration.
Local inflammation at the injection site has been reported.
Musculoskeletal side effects have included generalized bone, joint, or muscle pain.
Hepatic side effects associated with amphotericin B cholesteryl sulfate therapy have included elevated serum concentrations of alkaline phosphatase, ALT, AST, and bilirubin.
Hepatocellular toxicity, hepatomegaly, and veno-occlusive liver disease have been reported.
Rare genitourinary side effects have included hematuria and vaginal bleeding.
Psychiatric side effects have included depression, hallucinations, and abnormal thought processes.
Chills
fever
headache
nausea
Difficulty in breathing
dizziness or fainting
increased heartbeat
unusual bleeding or bruising
Difficulty in swallowing
hives
itching, especially of feet or hands
reddening of skin, especially around ears
swelling of eyes, face, or inside of nose
unusual tiredness or weakness (sudden and severe)
Vomiting